Curevac named as one of the world's most dynamic innovators by lexisnexis(r)

Curevac recognized as a top 100 innovator in acknowledgment of the company's innovative strength and extensive intellectual property portfolio the company holds one of broadest intellectual property portfolios in mrna technology tÜbingen, germany and boston, ma / accesswire / january 31, 2023 / curevac n.v. (nasdaq:cvac), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced its inclusion in the second annual "innovation momentum: the global top 100" report by lexisnexis®.
CVAC Ratings Summary
CVAC Quant Ranking